scieee Science in your language
[en] (orig)

Production of water soluble quercetin formulations by pressurized ethyl acetate-in-water emulsion technique using natural origin surfactants

Abstract

Producción Científica

Read accessible full text

Production of water soluble quercetin formulations by pressurized ethyl acetate-in-water emulsion technique using natural origin surfactants

Author: Gonçalves, Vanessa Santos Silva,Rodríguez Rojo, Soraya,Paz Barragan, Esther De,Mato, Cristina,Martín Martínez, Ángel,Cocero Alonso, María José
Publisher: Elsevier
Year: 2015
DOI: http://dx.doi.org/10.1016/j.foodhyd.2015.05.006
Source: https://uvadoc.uva.es/bitstream/10324/21598/1/Full_text_Final_srr.pdf
P oduc ion o wa e soluble que ce in o mula ions by p essu ized e hyl ace a e-in-wa e
1
emulsion echnique using na u al o igin su ac an s
2
V.S.S. Gonçal esa, b, c, S. Rod íguez-Rojoc, *, E. De Paz c, C. Ma o c, A. Ma ín c, M.J. Coce o c
3
a Ins i u o de Tecnologia Química e Biologica An onio Xa ie , Uni e sidade No a de Lisboa, A .
4
da República, 2780-157 Oei as, Po ugal
5
b iBET, Ins i u o de Biologia Expe imen al e Tecnologica, Apa ado 12, 2780-901 Oei as,
6
Po ugal
7
c Escuela de Ingenie ías Indus iales, Uni e sidad de Valladolid, C/D . Me gelina s/n, 47011
8
Valladolid, Spain
9
Abs ac
10
Que ce in is a s ong an ioxidan la onoid wi h se e al bioac i e p ope ies such as an i-
11
in lamma o y and an ica cinogenic ac i i ies, becoming an in e es ing compound o be
12
inco po a ed in o pha maceu ical, cosme ic o ood p oduc s. Howe e , hese applica ions a e
13
limi ed by he low bioa ailabili y o his la onoid. Que ce in is poo ly soluble in aqueous
14
media, such as gas oin es inal luids, being also deg aded by gu lo a. Thus, i is necessa y he
15
de elopmen o que ce in’s o mula ions capable o imp o ing i s wa e solubili y esul ing in
16
inc eased bioa ailabili y and hus highe biological ac i i y o his compound.
17
The aim o he p esen wo k was he o mula ion o que ce in using h ee dis inc na u al
18
o igin su ac an s, namely OSA-s a ch, Leci hin and β-glucan, by p ecipi a ion om a
19
p essu ized e hyl ace a e-in-wa e emulsion. Fo mula ions o que ce in wi h encapsula ion
20
e iciencies up o nea 76% and a micella pa icle size in he ange o nanome e s we e
21
ob ained using leci hin. An imp o ed an ioxidan ac i i y (3- old highe pe uni mass o
22
que ce in) was also obse ed in hese o mula ions, demons a ing ha leci hin is a good
23
emulsi ie o he encapsula ion o que ce in. Fu he mo e, he addi ion o glyce ol as co-
24
sol en inc eased he colloidal s abili y o he suspension and he encapsula ion e iciency
25
o he la onoid.
26
27
Keywo ds: Que ce in, OSA-s a ch, Leci hin, β-glucan, Encapsula ion, High P essu e Emulsion
28
Technique, Nanosuspension
29
30
1. In oduc ion
31
Que ce in (3,3',4',5,7-Pen ahyd oxy la one), one o he mos ep esen a i e membe o he
32
la onoid amily wi h high an ioxidan ac i i y, is commonly ound in se e al ui s and
33
ege ables like onions, apples, g apes o s awbe ies, as well as in ed wine o g een/black ea
34
[1,2]. This compound has a ac ed he in e es o he pha maceu ical and nu aceu ical
35
indus ies due o i s bioac i e p ope ies, such as an i-in lamma o y, an i-p oli e a i e and
36
neu op o ec i e e ec s [1,3]. In o de o achie e que ce in plasma’s concen a ion abo e 10
37
mM equi ed o ob aining pha macological ac i i y, he inges ion o que ce in-en iched oods
38
o supplemen s could no be enough due o he low bioa ailabili y o his la onoid [4]. The
39
low wa e solubili y (2ppm a 25ºC o 60 ppm a 100 °C) allied wi h gas oin es inal
40
deg ada ion limi s que ce in’s biological e ec s in i o [2,5]. The e a e wo main app oaches o
41
inc ease he bioa ailabili y o his compound, whe he by chemical modi ica ion o by he
42
de elopmen o colloidal que ce in deli e y sys ems [6].
43
Fo mula ions o que ce in using di e en me hods and dis inc ca ie ma e ials ha e been
44
de eloped by se e al au ho s. Rega ding polyme s, Kuma i and co-au ho s achie ed a
45
con olled elease o que ce in by i s encapsula ion in o poly-D,L-lac ide (PLA) nanopa icles
46
h ough sol en e apo a ion echnique [7]. Wu e al. ha e p oduced que ce in-loaded
47
nanopa icles by a nanop ecipi a ion me hod using Eud agi ® E and poly inyl alcohol (PVA) as
48
ca ie s, ob aining a que ce in’s elease 74- old highe in compa ison wi h he pu e compound
49
[8]. Que ce in was also encapsula ed in Plu onic F127 h ough supe c i ical an isol en me hod
50
by F aile and co-au ho s, enabling an imp o ed dissolu ion beha iou o he compound in
51
simula ed physiological luids [9]. Cyclodex ins (CD), such as α-CD, β-CD o HP-β-CD, ha e also
52
been used o he encapsula ion o que ce in using he eeze-d ying o co-e apo a ion
53
me hod [10,11]. Ba as and co-au ho s used lipids o encapsula e que ce in, being able o
54
inc ease i s appa en aqueous solubili y by a ac o o 100 [6]. Besides solid lipid nanopa icles,
55
nanos uc u ed lipid ca ie s and lipid nanoemulsions we e p oduced using a high p essu e
56
homogenize o he encapsula ion o que ce in by Adi ya e al., achie ing encapsula ion
57
e iciencies abo e 90% [12]. Que ce in-loaded liposomes ha e also been p oduced and a e
58
epo ed in he li e a u e [1,13]. Ino ganic ma e ials can also be an op ion as ca ie s o he
59
encapsula ion o que ce in and, ecen ly, que ce in-loaded silica mic osphe es we e de eloped
60
by Kim and co-au ho s using polyol-in-oil-in-wa e (P/O/W) emulsion and sol-gel me hods o
61
imp o e he la onoid’s s abili y as well as i s p ope ies [14].
62
In 2012, de Paz and co-au ho s [15] de eloped a no el me hod o he encapsula ion o
63
hyd ophobic compounds, based on he p oduc ion and p ocessing o e hyl ace a e-wa e
64
emulsions a high p essu e and empe a u e. The au ho s achie ed s able aqueous
65
suspensions o β-ca o ene wi h micella pa icle sizes down o 400 nm and encapsula ion
66
e iciencies up o 80%. Mo eo e , he ype o emulsi ie used had been shown o a ec he
67
inal p ope ies o he suspension [16]. This p ocess is an a ac i e al e na i e o he
68
con en ional emulsion e apo a ion p ocess, since i enables he accele a ion o he mass
69
ans e kine ics o he ime scales o he p ecipi a ion p ocesses. This in ensi ica ion o he
70
p ocess allows an imp o ed con ol o e he p ecipi a ion, a he same ime ha he
71
exposi ion o he p oduc o deg ading high- empe a u e condi ions is dec eased.
72
This wo k p esen s he de elopmen o wa e soluble o mula ions o que ce in h ough
73
p essu ized e hyl ace a e-wa e emulsion echnique. E hyl ace a e has been chosen as o ganic
74
sol en because i is a Gene ally Recognized as Sa e (GRAS) sol en wi h low oxici y (Le hal
75
Dose LD50 in a s: 11.3 g/kg) and i can be sa ely used as a la ou ing agen [17]. Th ee na u al
76
o igin su ac an s, namely modi ied n-oc enyl succina e anhyd ide (OSA) s a ch, soybean
77
leci hin and ba ley β-glucan, we e used in his wo k o he encapsula ion o que ce in. S a ch
78
is he second mos abundan biomass ma e ial p esen in na u e being he mos abundan
79
s o age polysaccha ide in plan s [18,19]. Howe e , na u al s a ch is mainly hyd ophilic, which
80
could limi i s applica ion in he encapsula ion o hyd ophobic compounds. Ne e heless, OSA
81
(modi ied amphiphilic s a ch) is capable o o e come his d awback, and was al eady used o
82
he encapsula ion and deli e y o compounds wi h dis inc pola i ies[19]. Leci hin is a mix u e
83
o na u ally occu ing phospholipids, mainly phospha idylcholine, which is usually a ailable
84
om sou ces such as soybeans o eggs. Phospholipids a e amphiphilic molecules composed by
85
hyd ophobic ails and hyd ophilic heads, being capable o ea ange hemsel es as liposomes,
86
sphe ical and closed s uc u es composed o lipid bilaye s [20,21]. Liposomes a e in e es ing
87
ca ie ma e ials o he deli e y o hyd ophobic/hyd ophilic compounds, and since hey ha e
88
a ini y o cellula memb anes, hey a e capable o inc ease he abso p ion o se e al d ugs
89
[22]. Besides he good p ope ies as encapsula ing agen and emulsi ie , leci hin is also known
90
o i s an ioxidan ac i i y [23]. β-glucans a e soluble ibe s p esen in ce eal g ains, especially
91
in ba ley, cons i u ed by linea polysaccha ides o glucose uni s, connec ed by (1 → 3) o (1 →
92
4)-be a linkages. These ca bohyd a es a e known o hei he apeu ic e ec s on co ona y
93
hea disease, diabe es and hype choles e olemia, and ha e been used as encapsula ing
94
agen s [24–27]. The in luence o he main p ocess pa ame e s has been s udied, namely he
95
e ec o que ce in and emulsi ie ’s concen a ion, he e ec o he lows o o ganic sol en ,
96
suspension o que ce in and dissolu ion o emulsi ie and also he o ganic o wa e a io. By
97
compa ing he esul s ob ained wi h he h ee di e en emulsi ie s, hei oles on he
98
emulsion o ma ion and que ce in’s encapsula ion can be es ablished. P oduc analysis
99
included pa icle size, encapsula ion e iciency, an ioxidan ac i i y and s uc u al
100
cha ac e isa ion.
101
102
2. Ma e ials and me hods
103
2.1. Ma e ials
104
Que ce in hyd a e (Q) wi h a (pu i y≥95%) was pu chased om Sigma-Ald ich. E hyl Ace a e
105
wi h a pu i y o 99.5% and glyce ol we e pu chased om Pan eac Química (Ba celona, Spain).
106
Modi ied OSA-s a ch e ined om waxy maize was kindly p o ided by Na ional S a ch G oup
107
(Hambu g, Ge many). Soybean leci hin (97% phospholipids) was ob ained om Glama-So
108
(SOTYA, Mad id, Spain). Glucagel™ (ba ley β-Glucan) was kindly supplied by DKSH F ance
109
(pu i y 78%, MW : 125 -140 kDa).
110
2.2. P ecipi a ion om p essu ized e hyl ace a e-on-wa e emulsions
111
The equipmen used in his wo k, al eady desc ibed by De Paz e al[15,16], is ep esen ed in
112
Fig. 1 wi h a schema ic low diag am.
113
(FIGURE 1)
114
B ie ly, i consis s o h ee small s o ages a ambien p essu e, co esponding o he eed o
115
pu e e hyl ace a e (V-1), que ce in suspension in he same o ganic sol en (V-2) and he
116
aqueous solu ion o he emulsi ie (V-3). The ins alla ion also coun s wi h wo pis on pumps
117
GILSON 305 (maximum low a e: 25 mL/min; low a e con ol wi h an a accu acy o 0.1
118
mL/min) used o eed he aqueous dissolu ion o he emulsi ie and he que ce in suspension
119
(pumps P-3 and P-2, espec i ely) and a pis on pump JASCO PU-2080 plus (maximum low a e:
120
10 mL/min; low con ol wi h an a accu acy o 0.1 mL/min) used o eed he pu e o ganic
121
sol en (pump P-1). An o en (KNK-2000-C se ies GAS CHROMATOGRAPH) is used o p ehea
122
he o ganic sol en s eam.
123

This p ocess s a s wi h he o al dissolu ion o que ce in in ho and p essu ized e hyl ace a e,
124
whe e by inc easing empe a u e, i is possible o inc ease he solubili y o que ce in in his
125
sol en , which is a ound 1g/L a ambien condi ions. In his wo k, a empe a u e, ypically,
126
be ween 125-140ºC was used, keeping a cons an p essu e be ween 6.0 and 6.5 MPa in o de
127
o main ain he sol en in liquid s a e. The dissolu ion is achie ed by mixing a la onoid’s
128
suspension in p essu ized e hyl ace a e a ambien empe a u e, wi h a s eam o p ehea ed
129
and p essu ized e hyl ace a e, using a T- mixe (M-1 in Fig. 1). In o de o educe he exposu e
130
o que ce in o high empe a u es, his ho and p essu ized solu ion is mixed wi h he
131
ambien - empe a u e aqueous solu ion o emulsi ie using he second T-mixe o he
132
equipmen (M2). The e o e, he con ac ime be ween que ce in and he ho sol en is
133
educed o less han wo seconds, a oiding he deg ada ion o he p oduc . The con ac o he
134
ho solu ion o que ce in wi h he aqueous solu ion in mixe M-2 causes he emulsi ica ion o
135
he o ganic sol en and he p ecipi a ion o que ce in by a combined an isol en and cooling
136
e ec . The las s ep is he emo al o he o ganic sol en om he o med emulsion using a
137
o a y e apo a o , in o de o ob ain an aqueous dispe sion o que ce in pa icles s abilized by
138
he su ac an .
139
A ypical expe imen s a ed wi h he p epa a ion o an aqueous solu ion o emulsi ie and a
140
suspension o que ce in in e hyl ace a e, which we e p e-hea ed and s i ed in o de o ob ain
141
homogeneous mix u es. A e wa ds, pumps we e swi ched on and he p essu e in he sys em
142
was ixed be ween 6.0 and 6.5 MPa. The o en was swi ched on o hea he o ganic sol en
143
un il he desi ed empe a u e (140-150ºC). When he equi ed empe a u e in mixe M-1 was
144
eached, he pu e sol en s used un il his momen we e eplaced wi h he que ce in
145
suspension, in con inuous agi a ion, and wi h he aqueous solu ion o he emulsi ie . In all
146
expe imen s, a olume o app oxima ely 25 mL o suspension con aining que ce in was
147
p ocessed. A e wa ds, he o ganic sol en o he ob ained emulsion was emo ed om he
148
sample using a o a y e apo a o (BÜCHI 011-BÜCHI 461 Wa e Ba h) unde acuum (-0.06,
149
60ºC and 110min), o elimina e he o ganic sol en .
150
2.3. P oduc cha ac e iza ion
151
2.3.1. Mic oscopy
152
An au oma ed up igh mic oscope sys em o li e science esea ch (Leica DM4000 B, We zla ,
153
Ge many) was used o ob ain mic oscopic images o he emulsions and suspensions.
154
2.3.2. Physical s abili y o emulsion
155
The physical s abili y o p epa ed emulsions was s udied h ough he op ical analyse
156
Tu biscan™ Classic on he p oduc ion day, by measu ing he a ia ions in backsca e ing.
157
2.3.3. Pa icle size
158
The pa icle size o he micelles we e measu ed by a Lase Di ac ion (LD) equipmen model
159
Mal e n Mas e size 2000 ollowing a cen i uga ion s ep a 7800 pm, 5min, in o de o
160
p ecipi a e he c ys als o que ce in ha we e no encapsula ed. Suspensions we e dispe sed
161
in dis illed wa e and measu emen was ca ied ou a e a gen le o a ion o he suspension
162
con aine in o de o ob ain a be e dispe sion o he micelles. In his wo k, pa icle size
163
measu emen s a e epo ed as olume dis ibu ion and de ined as he a e age diame e (d0.5).
164
2.3.4. Encapsula ion e iciency (EE)
165
Fo he que ce in’s wa e suspensions s abilized wi h s a ch he Encapsula ion E iciency (EE)
166
was de e mined h ough Ul a iole - isible spec opho ome y, while in he suspensions
167
s abilized wi h leci hin o β-glucan, due o he in e e ence o hese ca ie ma e ials on UV
168
assays, his pa ame e was de e mined by HPLC.
169
Fo UV-Vis measu emen s, he suspensions we e p e iously cen i uga ed a 7800 pm (5min)
170
and dilu ed in wa e . The concen a ion o que ce in was de e mined using a UV-Visible
171
Spec opho ome e (Shimadzu UV-2550, λ= 375 nm). Calib a ion was ob ained by using
172
s anda d samples wi h concen a ions be ween 3 and 12μg/mL, using e hanol as sol en .
173
HPLC analysis o que ce in was pe o med in acco dance wi h a me hod p e iously epo ed
174
[28]. A Wa e s 515 HPLC pump, equipped wi h In-Line Degasse AF (Wa e s), 717 plus
175
Au osample (Wa e s) and 2487 Dual ʎ Abso bance de ec o (Wa e s) we e used.
176
Ch oma og aphic sepa a ion was ca ied ou wi h a Symme y C18 Column (5 µm, 4.6 mm X
177
150 mm, Wa e s) coupled wi h a Bio-Sil C18 p ecolumn (5 µm, 4.6 mm X 30 mm, Bio-Rad) wi h
178
mobile phase o ace oni ile/5% ace ic acid solu ion (27:73, / ) a 30 ◦C. The de ec ion
179
wa eleng h was se a 373 nm and he low a e was 1.0 mL/min. The calib a ion cu e was
180
linea wi hin he ange o 25–200µg/mL (R2= 0.9997) using me hanol:wa e (70:30) solu ion as
181
sol en . The que ce in suspension samples we e de ec ed by HPLC ollowing cen i uga ion a
182
7800 pm (5min) and dilu ion in me hanol. The un ime o he assay was 13 min and he
183
e en ion ime o que ce in was 8.32 min.
184
The abso bance is p opo ional o he amoun o que ce in dispe sed in solu ion which
185
co esponds o he encapsula ed que ce in. Non-encapsula ed que ce in can co espond
186
ei he o que ce in p ecipi a ed as big c ys als and no s abilized in he suspension, o o
187
que ce in ha has unde gone deg ada ion du ing he p ocess. The encapsula ion e iciency is
188
epo ed as he a io be ween he amoun o la onoid dispe sed in solu ion and o al
189
que ce in amoun in he ini ial eed.
190
2.3.5. S uc u al cha ac e isa ion
191
In a ed spec a o he suspensions and pu e ma e ials we e eco ded on a B uke ALPHA FT-IR
192
appa a us equipped wi h a Pla inum ATR sampling module including a diamond c ys al. The
193
suspensions we e cen i uged a 13300 pm du ing 30min. The supe na an was emo ed and
194
he sample pelle ’s was submi ed o u he e apo a ion o wa e a -0.09MPa and 35ºC o
195
48h. The pelle was hen used o pe o m FTIR. The spec a in he ange om 4000 o 400 cm-1
196
we e he a e age o 64 scans a a esolu ion o 2cm-1. The ATR signal was ans o med o
197
T ansmi ance and he ob ained spec a was no malised a e he baseline co ec ion.
198
2.3.6. C yo-TEM
199
C yo-TEM analysis we e pe o med h ough a me hod al eady desc ibed [29]. B ie ly, 4μl o
200
sample was deposi ed on a ack C-Fla 1.2/1.3, which was p e iously hyd ophilized by a plasma
201
cleane . A blo ing is pe o med on ei he side o he il e pape g id du ing 4s whe e,
202
a e wa ds, liquid e hane is in oduced in o de o eeze he samples, a oiding he o ma ion
203
o c ys als (Ga an C yoplunge 3). Samples a e main ained in liquid ni ogen un il hei ans e
204
o he holde (Ga an C yo ans e 626). JEOL JEM-FS2200 HRP 200 kV TEM equipmen wi h
205
elec on il e ing was used o pe o m he TEM images.
206
2.3.7. S abili y o suspensions
207
One o he aqueous suspensions wi h he bes ela ion be ween EE and inal que ce in’s
208
concen a ion was chosen o s abili y examina ion. Some au ho s demons a ed ha i ’s
209
possible o inc ease he s abili y o leci hin, educing he appea ance o i s agglome a es and
210
inc ease d ug’s solubili y by adding glyce ol (G), as co-sol en , o aqueous leci hin dispe sions
211
[30,31]. Thus, an equal suspension wi h 2.5% ( / ) o glyce ol as co-sol en in he wa e phase
212
was p epa ed in o de o compa e he physicochemical p ope ies o he suspension wi hou
213
i . The s abili y examina ion was pe o med h ough he assessemen o micella pa icle size,
214
p esence o c ys als, que ce in’s concen a ion and an ioxidan ac i i y o he suspensions
215
a e 75 days o s o age in a e ige a ed da k oom (10ºC).
216
The assessmen o an ioxidan ac i i y was pe o med h ough oxygen adical abso p ion
217
capaci y (ORAC) assay, which was ca ied ou by a me hod p e iously desc ibed [32]. This assay
218
measu es he abili y o he an ioxidan species p esen in he sample o inhibi he oxida ion o
219
disodium luo escein (FL) ca alysed by pe oxyl adicals gene a ed om AAPH.
220
impo an o emembe ha u biscan only p o ides mean pa icle size alue bu no he
369
dispe sion o his alue, hence he di e ences be ween u biscan’s alues and op ical
370
mic oscope images.
371
Rega ding expe imen E20, c ys als o que ce in p ecipi a ed in he lask du ing he
372
e apo a ion o he emulsions, which was con i med by op ical mic oscopy. β-Glucan did no
373
seem o be a good ca ie /emulsi ie o encapsula e his la onoid, and so, highe
374
concen a ions o que ce in we e no es ed. The inal pa icle o he que ce in-loaded
375
micelles was in he mic ome e ange. In he case o E20, he p esence o que ce in’s c ys als
376
con ibu ed o he mic ome e size, whe eas in he samples E21-E23 he p esence o ca ie ’s
377
agglome a es con ibu ed o his pa icle size. Compa ing E20 and E22, i is possible o see ha
378
he addi ion o leci hin inc eased he pa icle size due o he o ma ion o leci hin:β-glucan
379
complexes [41]. Ne e heless, he addi ion o mo e leci hin (E21 and E23) led o a educ ion o
380
pa icle size, p obably due o he o ma ion o highe amoun o small sized que ce in
381
encapsula ed pa icles.
382
Rega ding he encapsula ion e iciency, i is possible o e i y ha compa ing E20 and E22, he
383
addi ion o leci hin o he sys em led o a dec ease o EE. The addi ion o leci hin led o he
384
complexa ion o he ca ie s, and hei u he p ecipi a ion. Pe haps he e is a compe i ion
385
be ween que ce in and leci hin o he complexa ion wi h β-glucan, esul ing in less EE in E22
386
compa ing wi h E20.
387
Ne e heless, as he amoun o he leci hin inc eased in β-glucan:leci hin mix u es
388
(E22<E21<E23), so as inc eased he EE o he sys em. These alues a e in ag eemen wi h he
389
educ ion o pa icle size in hese samples, as discussed p e iously. Pe haps in expe imen E23
390
he e is a highe po ion o ee leci hin, no complexed wi h β-glucan, o in e ac wi h
391
que ce in, inc easing i s encapsula ion. This ac ein o ces he capaci y o leci hin o
392
encapsula e que ce in
393
3.4. S abili y
394

Expe imen E17 was epea ed wi h and wi hou he inclusion o glyce ol in o de o e alua e
395
and compa e hei s abili y. Fo ha pu pose, he micella pa icle size, p esence o c ys als,
396
que ce in’s concen a ion and an ioxidan ac i i y o he esul ing suspensions we e measu ed
397
a e 75 days o s o age. Du ing his pe iod, he aqueous solu ions we e s o ed in a
398
e ige a ed oom a empe a u es a ound 10ºC and p o ec ed om ligh . The e ige a ion
399
condi ion was chosen o he s abili y s udy since i is ecommended as he s o age condi ion
400
o he phospholipids [42]. Resul s a e epo ed in Table 4.
401
(TABLE 4)
402
As p esen ed in his able, he sample p epa ed wi h glyce ol as co-sol en main ained
403
colloidal s abili y a he end o one mon h and a hal , wi h no signi ican change in i s pa icle
404
size, indica ing good s abili y du ing his pe iod. In con as , he sample wi hou glyce ol nea ly
405
ipled i s size a e he same pe iod, being his alue e en highe a e wo mon hs and a hal
406
a e i s p epa a ion.
407
(FIGURE 6)
408
E alua ing he shape o he size dis ibu ion, shown in Fig. 6, he dis ibu ion o he sample
409
eshly p epa ed ha e main peak in he nanome e s ange, co esponding o que ce in
410
pa icles ha we e success ully encapsula ed, and o he peaks a sizes abo e 1 µm possibly
411
co esponding o que ce in’s c ys als and leci hin’s agglome a es. Du ing s o age, he peaks
412
abo e 1 µm a e displaced o conside ably highe pa icle sizes, indica ing ha hese bigge
413
pa icles a e becoming mo e agglome a ed and u he des abilizing he suspension due o
414
hei highe size. The addi ion o a co-sol en is essen ial o an adequa e s abili y o he
415
o mula ion, a oiding no only he agglome a ion o leci hin, bu also delaying he appea ance
416
o que ce in’s c ys als. In ac , in he sample p epa ed wi hou glyce ol, he appea ance o
417
la onoid’s c ys als was obse ed sho ly a e i een days o p epa a ion. Rega ding
418
encapsula ion e iciency, he addi ion o a co-sol en appea ed o sligh ly enhance he
419
solubili y o que ce in in aqueous media. Ne e heless, he s abili y o que ce in o e s o age
420
was simila in he wo es ed samples.
421
Table 4 also shows he esul s achie ed by ORAC an ioxidan assay o he wo suspensions
422
o e s o age. The esul s a e exp essed as mic omoles o T olox equi alen s pe g am o
423
que ce in. An ioxidan ac i i y o pu e que ce in a e leci hin was also measu ed in his wo k,
424
e ealing alues o 6586 and 2.5 μmol o TE/g o p oduc , espec i ely. The p obable o ma ion
425
o hyd ogen bonds be ween leci hin and que ce in esul ed in a 3- old inc eased an ioxidan
426
ac i i y pe uni mass o que ce in o bo h suspensions, being hese alues nea ly p ese ed
427
a e 75 days o s o age.
428
4. Conclusion
429
The o mula ion o que ce in using h ee dis inc emulsi ie s, namely n-oc enyl succina e
430
anhyd ide s a ch, soybean leci hin and ba ley β-glucan, was in es iga ed in his wo k h ough
431
p essu ized e hyl ace a e-in-wa e emulsions. Resul s showed ha OSA-s a ch was no sui able
432
o he encapsula ion o que ce in due o he low encapsula ing e iciencies achie ed (below
433
10%) and micella pa icle sizes in he ange o mic ome e s. Expe imen s ca ied ou wi h
434
leci hin yielded he bes esul s, wi h encapsula ion e iciencies up o nea 76% and pa icle
435
sizes in he sub-mic ome e ange. Mo eo e , he aqueous suspensions o que ce in s abilized
436
wi h his su ac an p esen ed concen a ions o he la onoid up o 630ppm, being 315-
437
old highe compa ed wi h solubili y o pu e que ce in in wa e . The o ma ion o
438
hyd ogen bonds be ween leci hin and que ce in could explain he good esul s ob ained
439
wi h his emulsi ie , u he comp ising imp o ed an ioxidan ac i i y (3- old highe pe
440
uni mass o que ce in) due o a syne gis ic e ec . Fu he mo e, he addi ion o leci hin o
441
he emulsions s abilized wi h β-glucan imp o ed he encapsula ion e iciency and pa icle
442
size o he micelles, ein o cing he capaci y o leci hin o encapsula e que ce in.
443
The esul s ob ained in his wo k showed ha high p essu e emulsion echnique is a e sa ile
444
me hod o he p oduc ion o wa e soluble o mula ions o que ce in, a oiding que ce in’s
445
deg ada ion and inc easing i s solubili y. Fu he mo e, he addi ion o glyce ol as co-sol en
446
can inc ease he colloidal s abili y o he suspension and he encapsula ion e iciency o
447
he la onoid.
448
Acknowledgemen s
449
This wo k was suppo ed by Ma ie Cu ie Indus y-Academia Pa ne ships and Pa hways
450
(Eu opean Commission) h ough he WineSense p ojec (FP7-PEOPLE-2012- IAPP-612608).
451
V.S.S. Gonçal es is g a e ul o he doc o al g an SFRH/BD/77350/2011 om Fundação
452
pa a a Ciência e Tecnologia. S. Rod íguez-Rojo acknowledges he Minis e io de Economía y
453
Compe i i idad and Uni e sidad de Valladolid o he Juan de la Cie a ellowship (JCI-
454
2012-14992).
455
Re e ences
456
[1] A. P ip em, J. Wa ana o n, S. Su hipa inyanon , W. Phachonpai, S. Muchimapu a,
457
Anxie y and cogni i e e ec s o que ce in liposomes in a s., Nanomedicine. 4 (2008)
458
70–8.
459
[2] M.P. Souza, A.F.M. Vaz, M.T.S. Co eia, M.A. Ce quei a, A.A. Vicen e, M.G. Ca nei o-da-
460
Cunha, Que ce in-Loaded Leci hin/Chi osan Nanopa icles o Func ional Food
461
Applica ions, Food Biop ocess Technol. 7 (2013) 1149–1159.
462
[3] A.W. Boo s, G.R.M.M. Haenen, A. Bas , Heal h e ec s o que ce in: om an ioxidan o
463
nu aceu ical., Eu . J. Pha macol. 585 (2008) 325–37.
464
[4] M. Russo, C. Spagnuolo, I. Tedesco, S. Bilo o, G.L. Russo, The la onoid que ce in in
465
disease p e en ion and he apy: ac s and ancies., Biochem. Pha macol. 83 (2012) 6–
466
15.
467
[5] K. S ini as, J.W. King, L.R. Howa d, J.K. Mon ad, Solubili y and solu ion he modynamic
468
p ope ies o que ce in and que ce in dihyd a e in subc i ical wa e , J. Food Eng. 100
469
(2010) 208–218.
470
[6] A. Ba as, A. Mezze i, A. Richa d, S. Lazza oni, S. Roux, P. Melnyk, e al., Fo mula ion
471
and cha ac e iza ion o polyphenol-loaded lipid nanocapsules., In . J. Pha m. 379 (2009)
472
270–7.
473
[7] A. Kuma i, S.K. Yada , Y.B. Pakade, B. Singh, S.C. Yada , De elopmen o biodeg adable
474
nanopa icles o deli e y o que ce in, Colloids Su . B. Bioin e aces. 80 (2010) 184–
475
92.
476
[8] T.-H. Wu, F.-L. Yen, L.-T. Lin, T.-R. Tsai, C.-C. Lin, T.-M. Cham, P epa a ion,
477
physicochemical cha ac e iza ion, and an ioxidan e ec s o que ce in nanopa icles.,
478
In . J. Pha m. 346 (2008) 160–8.
479
[9] M. F aile, R. Bu a o, B. Goméz, Á. Ma ín, M.J. Coce o, Enhanced Deli e y o Que ce in
480
by Encapsula ion in Poloxame s by Supe c i ical An isol en P ocess, Ind. Eng. Chem.
481
Res. 53 (2014) 4318–4327.
482
[10] T. P alhad, K. Rajend akuma , S udy o eeze-d ied que ce in-cyclodex in bina y
483
sys ems by DSC, FT-IR, X- ay di ac ion and SEM analysis., J. Pha m. Biomed. Anal. 34
484
(2004) 333–9.
485
[11] M.L. Calab ò, S. Tommasini, P. Dona o, D. Rane i, R. S ancanelli, P. Fica a, e al., E ec s
486
o alpha- and be a-cyclodex in complexa ion on he physico-chemical p ope ies and
487
an ioxidan ac i i y o some 3-hyd oxy la ones., J. Pha m. Biomed. Anal. 35 (2004) 365–
488
77.
489
[12] N.P. Adi ya, A.S. Macedo, S. Dok o o o a, E.B. Sou o, S. Kim, P.-S. Chang, e al.,
490
De elopmen and e alua ion o lipid nanoca ie s o que ce in deli e y: A compa a i e
491
s udy o solid lipid nanopa icles (SLN), nanos uc u ed lipid ca ie s (NLC), and lipid
492
nanoemulsions (LNE), LWT - Food Sci. Technol. 59 (2014) 115–121.
493
[13] N. Migne , J. Seguin, G.G. Chabo , Bioa ailabili y o polyphenol liposomes: a challenge
494
ahead., Pha maceu ics. 5 (2013) 457–71.
495
[14] Y.H. Kim, D.W. Lee, E.J. Jung, J.T. Bae, S.G. Lee, H.B. Pyo, e al., P epa a ion and
496
cha ac e iza ion o que ce in-loaded silica mic osphe es s abilized by combined
497
mul iple emulsion and sol-gel p ocesses young, Chem. Ind. Chem. Eng. Q. (2014) 10–10.
498
[15] E. de Paz, Á. Ma ín, A. Es ella, S. Rod íguez-Rojo, A.A. Ma ias, C.M.M. Dua e, e al.,
499
Fo mula ion o β-ca o ene by p ecipi a ion om p essu ized e hyl ace a e-on-wa e
500
emulsions o applica ion as na u al colo an , Food Hyd ocoll. 26 (2012) 17–27.
501
[16] E. de Paz, Á. Ma ín, A. Ba olomé, M. La go, M.J. Coce o, De elopmen o wa e -
502
soluble β-ca o ene o mula ions by high- empe a u e, high-p essu e emulsi ica ion and
503
an isol en p ecipi a ion, Food Hyd ocoll. 37 (2014) 14–24.
504
[17] W.I.R. Iemenschneide , H. Ag, F. Republic, Ullmann’s Encyclopedia o Indus ial
505
Chemis y, Wiley-VCH Ve lag GmbH & Co. KGaA, Weinheim, Ge many, 2000.
506
[18] S.K. Ni a, K. Numa a, Biopolyme -based nanopa icles o d ug/gene deli e y and
507
issue enginee ing., In . J. Mol. Sci. 14 (2013) 1629–54.
508
[19] M. Fa hi, Á. Ma ín, D.J. McClemen s, Nanoencapsula ion o ood ing edien s using
509
ca bohyd a e based deli e y sys ems, T ends Food Sci. Technol. 39 (2014) 18–39.
510
[20] L. Boua ab, B. Mahe ani, A. Khei olomoom, M. Hasan, B. Aliakba ian, M. Linde , e al.,
511
In luence o leci hin-lipid composi ion on physico-chemical p ope ies o
512
nanoliposomes loaded wi h a hyd ophobic molecule., Colloids Su . B. Bioin e aces.
513
115 (2014) 197–204.
514
[21] P.C. Su iyakala, S.B. N, S.R. D, L. P abaka an, Phospholipids as e sa ile polyme in d ug
515
deli e y sys ems, In . J. Pha m. Pha m. Sci. 6 (2014) 6–9.
516
[22] S. Hoelle , A. Spe ge , C. Valen a, Leci hin based nanoemulsions: A compa a i e s udy
517
o he in luence o non-ionic su ac an s and he ca ionic phy osphingosine on
518
physicochemical beha iou and skin pe mea ion., In . J. Pha m. 370 (2009) 181–6.
519
[23] Y. Pan, R. V Tikeka , N. Ni in, E ec o an ioxidan p ope ies o leci hin emulsi ie on
520
oxida i e s abili y o encapsula ed bioac i e compounds., In . J. Pha m. 450 (2013) 129–
521
37.
522
[24] D. Cha alampopoulos, R. Wang, S.S. Pandiella, C. Webb, Applica ion o ce eals and
523
ce eal componen s in unc ional oods: a e iew., In . J. Food Mic obiol. 79 (2002) 131–
524
41.
525
[25] P.J. Wood, Ce eal β-glucans in die and heal h, J. Ce eal Sci. 46 (2007) 230–238.
526
[26] K. Raemdonck, T.F. Ma ens, K. B aeckmans, J. Demees e , S.C. De Smed ,
527
Polysaccha ide-based nucleic acid nano o mula ions, Ad . D ug Deli . Re . 65 (2013)
528
1123–47.
529
[27] Y. Wang, J. Liu, F. Chen, G. Zhao, E ec s o molecula s uc u e o polyphenols on hei
530
nonco alen in e ac ions wi h oa β-glucan., J. Ag ic. Food Chem. 61 (2013) 4533–8.
531
[28] L. Gao, G. Liu, X. Wang, F. Liu, Y. Xu, J. Ma, P epa a ion o a chemically s able que ce in
532
o mula ion using nanosuspension echnology., In . J. Pha m. 404 (2011) 231–7.
533
[29] L. Melanson, C yoplungeTM3 and Sola us® 950: a Pe ec Due o High Quali y F ozen
534
Hyd a ed Specimen P epa a ions o C yoEM,, Mic osc. Mic oanal. 15 (2009) 2–3.
535
[30] M. Płaczek, M. Szni owska, J. Jacyna, The in luence o co-sol en s and su ac an s on
536
physicochemical p ope ies o aqueous leci hin dispe sions ( WLD ) in ended o
537
pa en e al adminis a ion, in: 9 h Wo ld Mee . Pha m. Biopha m. Pha m. Technol.,
538
Lisbon, Po ugal, 2014.
539
[31] D. Wa obska-Swie likowska, M. P zybylo, J. P ocek, M. Szni owska, Dis ibu ion o
540
phospha idylcholine in o liposomal- micella and aqueous phases o submic on
541
emulsions s abilized wi h leci hin and phospholipids, in: 9 h Wo ld Mee . Pha m.
542
Biopha m. Pha m. Technol., Lisbon, Po ugal, 2014.
543
[32] B. Ou, D. Huang, M. Hampsch-Woodill, J. a Flanagan, E.K. Deeme , Analysis o
544
an ioxidan ac i i ies o common ege ables employing oxygen adical abso bance
545
capaci y (ORAC) and e ic educing an ioxidan powe (FRAP) assays: a compa a i e
546
s udy., J. Ag ic. Food Chem. 50 (2002) 3122–8.
547

[33] S. Va ona, Á. Ma ín, M.J. Coce o, Fo mula ion o a na u al biocide based on la andin
548
essen ial oil by emulsi ica ion using modi ied s a ches, Chem. Eng. P ocess. P ocess
549
In ensi . 48 (2009) 1121–1128.
550
[34] S. Va ona, A. Ma n, M.J. Coce o, Liposomal Inco po a ion o La andin Essen ial Oil by
551
a Thin-Film Hyd a ion Me hod and by Pa icles om Gas-Sa u a ed Solu ions, Ind. Eng.
552
Chem. Res. 50 (2011) 2088–2097.
553
[35] E. de Paz, Á. Ma ín, M.J. Coce o, Fo mula ion o β-ca o ene wi h soybean leci hin by
554
PGSS (Pa icles om Gas Sa u a ed Solu ions)-d ying, J. Supe c i . Fluids. 72 (2012) 125–
555
133.
556
[36] R.S. Nasibullin, T.I. Niki ina, Y. A anas’e a, T.R. Nasibullin, L.V. Spi ikhin, Complex o
557
3,5,7,3?,4?-pen ahyd oxypla onol wi h phospa idylcholine, Pha m. Chem. J. 36 (2002)
558
492–495.
559
[37] M.F. Ramadan, An ioxidan cha ac e is ics o phenolipids (que ce in-en iched leci hin)
560
in lipid ma ices, Ind. C ops P od. 36 (2012) 363–369.
561
[38] M.F. Ramadan, Phenolipids : New Gene a ion o An ioxidan s wi h Highe
562
Bioa ailabili y, Aus in J. Nu . Food Sci. 1 (2014) 2–3.
563
[39] Y. Li, Y. Yang, T. Bai, J. Zhu, Hea Capaci y o he Bina y Sys em o Que ce in and
564
Poly( inylpy olidone) K30, J. Chem. Eng. Da a. 55 (2010) 5856–5861.
565
[40] Y. Zheng, A.H.L. Chow, P oduc ion and cha ac e iza ion o a sp ay-d ied hyd oxyp opyl-
566
be a-cyclodex in/que ce in complex., D ug De . Ind. Pha m. 35 (2009) 727–34.
567
[41] M. Ve e ka, T. Dubaj, J. Gallo ič, V. Jo k, E. Ve e ko á, M. Mičušk, e al., Be a-glucan
568
complexes wi h selec ed nu aceu icals: Syn hesis, cha ac e iza ion, and s abili y, J.
569
Func . Foods. 8 (2014) 309–318.
570
[42] A.A. Da e, M.S. Naga senke , S. Pa e e, V. Dhawan, R.P. Gude, P. a Hassan, e al.,
571
Leci hin-based no el ca ionic nanoca ie s (Leciplex) II: imp o ing he apeu ic e icacy
572
o que ce in on o al adminis a ion., Mol. Pha m. 8 (2011) 716–26.
573
574